Pacira BioSciences :
PCRX
PCRX
Stock Data
$23.62
$0.24 (1.01%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Pacira BioSciences Inc specializes in creating non-opioid pain management and regenerative health solutions. Their product lineup includes EXPAREL, a pain relief injectable, ZILRETTA, an extended-release injection for managing osteoarthritis pain, and the iovera system, a device offering temporary pain relief through cold therapy. The company, rooted in innovation for safer pain management, also collaborates on NOCITA, another pain relief injectable. Founded in 2006 and based in Tampa, Florida, Pacira is committed to reducing reliance on opioids in healthcare.
All Pacira BioSciences Articles
30 Articles